Alvameline Tartrate

N/A

Report date: 2022/05/16 10:20:18
NME

Base Information

Drug NameAlvameline Tartrate
Drug Alias Name酒石酸阿伐美林alvamelinaalvamelinum阿伐美林酒石酸盐alvameline +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonistsMuscarinic acetylcholine receptor M1 agonistsMuscarinic acetylcholine receptor M2 antagonists
TargetsMuscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan PlcH. Lundbeck A/S
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG